NHS National Framework for Transition products commencing 1 May 2024
Estimated value
—
Awarded value
—
Suppliers
14
Lots
2
Published
24 Apr 2024
Description
Project title: NHS National Framework for Transition products commencing 1 May 2024<br/>Offer reference number: CM/TNS/05/2024<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/05/2024/01<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)<br/><br/>CM/TNS/05/2024/02<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Scope
- Reference
- CM/TNS/05/2024
- Commercial tool
- Standalone contract
- Contract dates
- 30 Apr 2024 to 30 Sept 2025
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 14 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin | £138.0m | cancelled |
| 2 | CM/TNS/05/2024/02 - Apixaban, Sapropterin | £41.4m | cancelled |